Daekitech
Latest round
- Seed
Last raised
- Dec 2017
Total raised
- Undisclosed
Investors
- 2
About Daekitech
Founded in 2015 in Santiago, Chile, Daekitech focuses on creating specialized antibody products. The company has undergone no significant pivots in its strategy and does not have parent or subsidiary relationships. Amanda Céspedes, the founder, has established the company without previous ventures in the biotechnology sector.Daekitech specializes in the development and commercialization of high-specificity antibodies designed for advanced research in various biomedical fields. Their primary product offerings include antibodies such as the Bassoon Antibody: PerCP, TAF10 Rabbit Polyclonal Antibody, Smad2 (Phospho-Ser467) Antibody, IFI44 Antibody, SHOX2 Polyclonal Antibody, Rabbit anti-HOXA13 Antibody, and POK7 Antibody, among others. These antibodies cater to numerous applications, including immunofluorescence, Western blotting, flow cytometry, and chromatin immunoprecipitation, serving as essential tools for researchers investigating synaptic function, transcriptional regulation, immune responses, and cancer biology.Daekitech generates revenue through direct sales of its specialized antibody products to research institutions and laboratories around the world. The transaction structure revolves around direct-to-consumer sales, allowing clients to place orders for specific antibodies according to their research needs. Customers can acquire products through individual purchases or bulk orders, addressing their ongoing research requirements. The pricing aligns with the advanced nature of the products, reflecting the high specificity and rigorous validation each antibody undergoes prior to sale.Daekitech is planning to expand its product line by developing new antibodies with anticipated launches in the upcoming year.
Who invested in Daekitech
2 investors across 1 round
See all investors in Daekitech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 22, 2017
Amount
Undisclosed
Investors
Questions about Daekitech
Who invested in Daekitech?
Daekitech has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Daekitech raised?
Daekitech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Daekitech last raise money?
Daekitech's most recent round on record is a Seed, in Dec 2017.
What does Daekitech do?
Founded in 2015 in Santiago, Chile, Daekitech focuses on creating specialized antibody products.
Where is Daekitech headquartered?
Daekitech is headquartered in Santiago, Chile.
Which VCs invest in companies like Daekitech?
Among active investors with capital left to deploy, Crescera Capital, Apex Group, Kaszek Ventures and dao5 back medical devices & equipment companies at Daekitech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Daekitech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.